RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $882K of Relay Therapeutics, Inc.
Sold$881,720
$20.99Price
42,000Shares
−3%Stake
What RLAY did after the filing
- The stock from Thu, Feb 9 close, $20.07
- −23.7%
- S&P 500, same days
- −2.4%
Measured over 30 trading days, to the Mar 24 close.
Traded Tue, Feb 7. Filed Thu, Feb 9, 12:09 PM ET, during the session. Returns use the Feb 9 close and the Mar 24 close. Not investment advice.